23
Views
9
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Antimicrobial Susceptibility, Biochemical and Genetic Profiles of Staphylococcus haemolyticus Strains Isolated from the Bloodstream of Patients Hospitalized in Critical Care Units

Pages 264-269 | Published online: 20 Nov 2013

References

  • Pfaller MA, Herwaldt LA. Laboratory, clinical, and epi-demiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281–299.
  • Karlowsky JA, Jones ME, Draghi DC, Thornsberry CS, Daniel FV, Gregory A Prevalence and antimicrobial suscepti-bilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004; 10: 3–7
  • Froggatt JV, Johnston JL, Galetto DW, Archer GL. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother 1989; 33: 460–466
  • Santos Sanches I, Mato R, de Lencastre H, Tomasz A, CEM/NET Collaborators and the International Collaborators. Patterns of multidrug resistance among methillicin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 2000; 6: 199–211.
  • Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occur-rence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY antimicrobial surveil-lance program, 1997-1999. Clin Infect Dis 2001; 32 (52): S114–S132.
  • Bjorkqvist M, Soderquist B, Tornqvist E, et al. Phenotypic and genotypic characterisation of blood isolates of coagulase-negative staphylococci in the newborn. APMIS 2002; 110 (4): 332–339.
  • Raimundo O, Heussler H, Bruhn JB, et al. Molecular epidemiology of coagulase-negative staphylococcal bacter-aemia in a newborn intensive care unit. J Hosp Infect 2002; 51 (1): 33–42.
  • Petinaki E, Kontos F, Miriagou V, Maniati M, Hatzi F, Maniatis A, Bacterial Resistance Study Group. Survey of methicillin-resistant coagulase-negative staphylococci in the hospitals of central Greece. Int J Antimicrob Agents 2001; 18 (6) :563–566.
  • Burnie JP, Naderi-Nasab M, Loudon KW, Matthews RC. An epidemiological study of blood culture isolates of coagu-lase-negative staphylococci demonstrating hospital-acquired infection. J Clin Microbiol 1997; 35 (7): 1746–1750.
  • Neumeister B, Kastner S, Conrad S, Klotz G, Bartmann P. Characterization of coagulase-negative staphylo-cocci causing nosocomial infections in preterm infants. Eur J Clin Microbiol Infect Dis 1995; 14 (10): 856–863.
  • Cercenado E, Garcia-Leoni ME, Diaz MD et al. Emergence of teicoplanin-resistant coagulase-negative staphy-lococci. J Clin Microbiol 1996; 34: 1765–1768.
  • Lallemand S, Thouverez M, Boisson K, Talon D, Bertrand X. Bacteraemia caused by coagulase-negative staphy-lococci exhibiting decreased susceptibility to teicoplanin. J Hosp Infect 2002; 51 (3) :207–214.
  • Spiliopoulou I, Santos Sanches I, Bartzavali C, et al. Application of molecular typing methods to characterize noso-comial coagulase-negative staphylococci collected in a Greek hospital during a three-year period (1998-2000). Microb Drug Resist 2003; 9 (3): 273–282.
  • Sloos JH, Dijkshoorn L, Vogel L, van Boven CPA. Performance of phenotypic and genotypic methods to deter-mine the clinical relevance of serial blood isolates of Staphylococcus epidermidis in patients with septicemia. J Clin Microbiol 2000; 38: 2488–2493.
  • Wang XM, Noble L, Kreiswirth BN, et al. Evaluation of a multilocus sequence typing system for Staphylococcus epi-dermidis. J Med Microbiol 2003; 52: 989–998.
  • Schlegel L, Saliba F, Mangeney N, Mathieu D. Pulsed field gel electrophoresis typing of coagulase-negative staphylo-cocci with decreased susceptibility to teicoplanin isolated from an intensive care unit. J Hosp Infect 2001; 49: 62–68.
  • Perl TM, Kruger WA, Houston A, Boyken LD, Pfaller MA, Herwaldt LA. Investigation of suspected nosocomial clus-ters of Staphylococcus haemolyticus infections. Infect Control Hosp Epidemiol 1999; 20 (2): 128–131.
  • Biavasco F, Vignaroli C, Lazzarini R, Varaldo PE. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob Agents Chemother 2000; 44: 3122–3126.
  • Shittu A, Lin J, Morrison D, Kolawole D. Isolation and molecular characterization of multiresistant Staphylococcus sciuri and Staphylococcus haemolyticus associated with skin and soft-tissue infections. J Med Microbiol 2004; 53: 51–55.
  • Tabe Y, Nakamura A, Oguri T, Igari J. Molecular char-acterization of epidemic multiresistant Staphylococcus haemolyticus isolates. Diagn Microbiol Infect Dis 1998; 32: 177–183.
  • National Committee for Clinical Laboratory Standards. Performance Standard for Antimicrobial Susceptibility Testing. Sixth Informational Supplement. Approved Standard M100-S6 Wayne, PA National Committee for Clinical Laboratory Standards, 1995.
  • National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically. Fourth Edition Approved Standard M7-A5 and M100-S10 Wayne, PA: National Committee for Clinical Laboratory Standards, 2001.
  • Walsh TR, Bolmstrom A, Qwärnstrom A, et al. Evaluaition of current methods for detecton of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439–2444.
  • Schreckenberger PC, Ilendo E, Ristow K. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42 (6): 2777–2779.
  • Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbpla-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis 2000; 181 (1): 216–229.
  • Pfaller MA, Hollis RJ, Sader HS Chromosomal restric-tion fragment analysis by pulsed-field gel electrophoresis. In: Isenberg HD ed. Clinical Microbiology Procedures Handbook, 2 ed. Washington, DC. American Society for Clinical Microbiology, 1992; (suppl.10.5c): 1-12.
  • Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233–2239.
  • Goering RV, Tenover FC. Epidemiological interpreta-tion of chromosomal macro-restriction fragment pattern ana-lyzed by pulsed-field gel electrophoresis. J Clin Microbiol 1997; 35 (9): 2432–2433.
  • Del'Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Antimicrobial susceptibility of coagulase-negative staphylo-cocci and characterization of isolates with reduced susceptibili-ty to glycopeptides. Diagn Microbiol Infect Dis 1999; 34: 185–191.
  • Sloos JH, Dijkshoorn L, Van Boven CPA. Septicaemias caused by a strain of Staphylococcus haemolyti-cus exhibiting intermediate susceptibility to teicoplanin in mul-tiple intensive care unit patients. J Antimicrob Chemother 2000; 45: 410–411.
  • Ghezzi MC, Mancini C, LavaIle G, Raponi G. Surveillance of antibiotic-resistance of staphylococci in a large teaching hospital in Rome. Clin Microbiol Infect 2002; 8 (suppl 1): 6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.